FDA takes first step in possible reversal of ban on some peptides The Washington Post The peptide conversation is shifting. Secretary RFK Jr. recently announced that the FDA plans to move 14 peptides from Category 2 back to Category 1 restoring FDA recognized status and making them FDA to Consider Lifting Restrictions on Numerous Compounded Peptides Foley & Lardner Peptides in 2026, What the FDA Review Means Olympia Pharmaceuticals Orthopedic Use of BPC 157 Sports Med Review Are Peptides coming off of the FDA Category 2 list? A legal breakdown.